The BioHire Journal

We've all heard the buzz about GLP-1 agonists such as Ozempic. Though these drugs have been around for some time, we've seen a huge increase in their demand in the last year, both for their original use as type 2 diabetes treatments and as popular weight loss aids. This huge boom in the market has the potential to change the landscape of talent acquisition in pharma as well. Check out this article from Precision Business Insights for a deeper dive into the dynamics of the GLP-1 agonists market, and its predicted effects on biopharma and talent acquisition within the field: https://loom.ly/_Gg3F7M And head to our BioHire RoundUp for more highlights in biopharma news: https://loom.ly/axa08SE #Biopharma #BiopharmaNews #GLP-1 #Ozempic #BioHireRoundUp #TheBioHireJournal

In this latter half of 2024, following a hopeful uptick for the biotech industry in the first half, it’s more important than ever to stay on top of the quickly evolving news. Some of the most crucial developments to keep up with are the approaching FDA approval dates, which provide insight into the industry’s outlook for the rest of the year and into 2025. Check out a rundown of upcoming decision dates in the third quarter of 2024 here: https://loom.ly/j4NaDaw #BiotechNews #FDADecisionDates #BiopharmaNews #PDUFAs #TheBioHireJournal

With the Presidential election just over thirty days away, healthcare and economic growth remain two of the most important issues to voters. At the intersection of these areas is the biotech space, and the effect of Trump versus Harris' policy on the industry is poised to be significant. This article from our recent BioHire RoundUp explores the potential impacts of each candidate's presidency on the biotech industry, and how we might expect to see this unfold during this new presidency: https://loom.ly/R-hi2-g Check out our BioHire RoundUp for more timely biotech news: https://loom.ly/axa08SE

A recent study conducted by The Josh Bersin Company found that senior talent acquisition professionals often feel “…left out of their company’s strategic planning process and ... [that] they operate as ‘order takers’”. This disappointing finding connects to a larger phenomenon within the talent acquisition world of today, as companies cut their TA spending in the midst of worsening skills shortages, and points to a need for significant change within the field. Read Josh Bersin’s article, which delves into this problem and explores possible industry-wide solutions: https://loom.ly/vH6NdKY And check out our BioHire RoundUp for other timely updates on the state of biotech and talent acquisition today: https://loom.ly/axa08SE #JoshBersinCompany #TalentAcquisition #SkillsShortages #Recruiting #TheBioHireJournal

As AI software grows more commonplace and more capable, many fields will experience a shift in hiring needs and priorities, and recruiting is no different. Our recent BioHire RoundUp explores AI’s expected effect on the recruiting sphere, and how one can best adapt to these evolving circumstances. Check it out at the link in our bio. #AI #Recruiting #TalentAcquisition #TheBioHireJournal

In a recent LinkedIn poll, only 20% of recruiters reported they felt very secure in their current roles, with the vast majority reporting feeling somewhat secure or not secure at all in their positions. Coupled with the jobs report showing slowing job growth and rising unemployment, this paints a concerning portrait of the talent acquisition industry in 2024. So, how can recruiters and other TA professionals navigate this tumultuous period? Read our third issue's BioHire RoundUp for our advice, as well as other thought-provoking content at the intersection of life sciences and talent acquisition: https://loom.ly/axa08SE #TalentAcquisition #Recruiting #BioHireRoundUp #TheBioHireJournal

Recruiters and other talent acquisition professionals are often exposed to a wide range of human behavior, and interview experiences can span from positive to negative to downright strange. In our new article, we’ve compiled some of the most unexpected and unforgettable interview anecdotes reported by talent acquisition professionals across the internet: https://loom.ly/cIluZNs #JobInterview #TalentAcquisition #HiringManager #TheBioHireJournal

Within the increasingly competitive life sciences job market, employment scams taking advantage are on the rise. Read The BioHire Journal’s recent article for an exploration of this growing phenomenon, the risks and reasons behind it, and accounts from those who’ve experienced these scams firsthand: https://loom.ly/P3tYGz4 #EmploymentScams #JobScams #LifeSciences #JobMarket #SciBioRecruiting

The biopharma industry is in a period of upheaval, with layoffs affecting both larger pharma companies and smaller biotechs. Though the U.S. Bureau of Labor Statistics states that employment in this sector has been growing since at least 1992, data also shows a continual decrease in new scientific research and development jobs from a peak in 2022. But what are the reasons behind this current instability in the industry, and how can you best adapt to this new and continually evolving landscape? Read our new article for insight into 2024 unemployment trends in biopharma: https://loom.ly/nlYh_RM #Unemployment #Biopharma #Layoffs #TheBioHireJournal

💡 Our CEO, Javan Collins, recently shared his valuable insights with The BioHire Journal regarding the current state of the #biopharma job market. He discussed the challenges and opportunities that professionals face while navigating the industry. #biopharmajobs #industrytrends #leadership #Vanigent https://lnkd.in/ek9wdSJD